NCYT.L
Price:
$55.6
Market Cap:
$39.27M
Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segme...[Read more]
Industry
Medical - Devices
IPO Date
2017-11-01
Stock Exchange
LSE
Ticker
NCYT.L
According to Novacyt S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 4.04. This represents a change of 163.10% compared to the average of 1.54 of the last 4 quarters.
The mean historical Current Ratio of Novacyt S.A. over the last ten years is 2.09. The current 4.04 Current Ratio has changed 19.22% with respect to the historical average. Over the past ten years (40 quarters), NCYT.L's Current Ratio was at its highest in in the September 2022 quarter at 5.25. The Current Ratio was at its lowest in in the September 2014 quarter at 0.
Average
2.09
Median
1.35
Minimum
0.83
Maximum
5.25
Discovering the peaks and valleys of Novacyt S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.23%
Maximum Annual Current Ratio = 5.25
Minimum Annual Increase = -62.14%
Minimum Annual Current Ratio = 0.83
Year | Current Ratio | Change |
---|---|---|
2023 | 2.10 | -59.95% |
2022 | 5.25 | 28.63% |
2021 | 4.08 | 47.62% |
2020 | 2.76 | 174.23% |
2019 | 1.01 | -0.34% |
2018 | 1.01 | -27.82% |
2017 | 1.40 | 67.90% |
2016 | 0.83 | -35.49% |
2015 | 1.29 | 11.01% |
2014 | 1.17 | -62.14% |
The current Current Ratio of Novacyt S.A. (NCYT.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.81
5-year avg
3.04
10-year avg
2.09
Novacyt S.A.’s Current Ratio is less than Omega Diagnostics Group PLC (4.29), greater than Avacta Group Plc (1.29), greater than genedrive plc (1.63), less than Synairgen plc (9.76), less than Hemogenyx Pharmaceuticals Plc (4.38),
Company | Current Ratio | Market cap |
---|---|---|
4.29 | $4.94M | |
1.29 | $190.99M | |
1.63 | $12.66M | |
9.76 | $9.06M | |
4.38 | $17.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novacyt S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novacyt S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Novacyt S.A.'s Current Ratio?
How is the Current Ratio calculated for Novacyt S.A. (NCYT.L)?
What is the highest Current Ratio for Novacyt S.A. (NCYT.L)?
What is the 3-year average Current Ratio for Novacyt S.A. (NCYT.L)?
What is the 5-year average Current Ratio for Novacyt S.A. (NCYT.L)?
How does the current Current Ratio for Novacyt S.A. (NCYT.L) compare to its historical average?